Capricor Therapeutics Overview
Capricor Therapeutics Target Price
Analysts' 12-month price predictions for CAPR.
Get informed when a big investor buys or sells
+ FollowShare Price
$29.51
Average Target Price
$50.00
69.4% upside
69.4% upside2 analysts in the last 4 months
High: $62 | Low: $38
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-15 | Roth CapitalBoobalan Pachaiyappan | $38 | 28.8% upside |  |
| 2026-03-13 | Cantor FitzgeraldKristen Kluska | $62 | 110.1% upside | |
| 2025-12-15 | UBS | $50 | 69.4% upside | |
| 2025-12-10 | Piper Sandler | $45 | 52.5% upside | |
| 2025-12-08 | Oppenheimer | $54 | 83% upside | |
| 2025-12-04 | Maxim Group | $50 | 69.4% upside | |
| 2025-12-03 | Industrial Alliance Securities | $48 | 62.7% upside | |
| 2025-12-03 | H.C. Wainwright | $60 | 103.3% upside | |
| 2025-11-11 | Roth CapitalBoobalan Pachaiyappan | $13 |  55.9% downside | |
| 2025-07-11 | Piper SandlerEdward Tenthoff | $20 | 32.2% downside | |
| 2025-07-11 | H.C. WainwrightJoseph Pantginis | $24 | 18.7% downside | |
| 2024-10-21 | Piper SandlerEdward Tenthoff | $17.5 | 40.7% downside | |
| 2024-10-14 | OppenheimerLeland Gershall | $21.5 | 27.1% downside | |
| 2024-09-25 | Maxim GroupJason McCarthy | $12.5 | 57.6% downside | |
| 2024-09-25 | H.C. WainwrightJoseph Pantginis | $10 | 66.1% downside | |
| 2024-09-17 | OppenheimerLeland Gershall | $7.5 | 74.6% downside | |
| 2024-05-16 | OppenheimerLeland Gershall | $7 | 76.3% downside | |